Efficacy and Safety of Ezetimibe Coadministered With Simvastatin in Patients With Primary Hypercholesterolemia: A Randomized, Double-Blind, Placebo-Controlled Trial
- 1 May 2004
- journal article
- clinical trial
- Published by Elsevier in Mayo Clinic Proceedings
- Vol. 79 (5) , 620-629
- https://doi.org/10.4065/79.5.620
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Efficacy and safety of ezetimibe coadministered with pravastatin in patients with primary hypercholesterolemia: a prospective, randomized, double-blind trialEuropean Heart Journal, 2003
- Effects of ezetimibe, a new cholesterol absorption inhibitor, on plasma lipids in patients with primary hypercholesterolemiaEuropean Heart Journal, 2003
- Efficacy and safety of ezetimibe coadministered with lovastatin in primary hypercholesterolemiaThe American Journal of Cardiology, 2003
- Addressing a Treatment GapClinical Drug Investigation, 2002
- Fatal Rhabdomyolysis Caused by Lipid-Lowering TherapySouthern Medical Journal, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Plasma concentrations of active simvastatin acid are increased by gemfibrozilClinical Pharmacology & Therapeutics, 2000
- Comparison of the activity and disposition of the novel cholesterol absorption inhibitor, SCH58235, and its glucuronide, SCH60663British Journal of Pharmacology, 2000
- Drug Treatment of Lipid DisordersNew England Journal of Medicine, 1999
- Drug Interactions of Lipid-Altering DrugsDrug Safety, 1998